Financhill
Buy
71

NHC Quote, Financials, Valuation and Earnings

Last price:
$169.49
Seasonality move :
4.89%
Day range:
$169.24 - $174.51
52-week range:
$89.14 - $174.51
Dividend yield:
1.46%
P/E ratio:
22.53x
P/S ratio:
1.79x
P/B ratio:
2.51x
Volume:
63.1K
Avg. volume:
71.7K
1-year change:
86.42%
Market cap:
$2.7B
Revenue:
$1.5B
EPS (TTM):
$7.67

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
NHC
National HealthCare Corp.
-- -- -- -- --
AGL
Agilon Health, Inc.
$1.5B -$0.27 -8.95% -1095.65% $0.94
CVS
CVS Health Corp.
$103.6B $1.00 1.11% 58.73% $96.38
HUM
Humana, Inc.
$32B -$3.99 19.94% -4.03% $223.88
INNV
InnovAge Holding Corp.
$228.3M $0.04 7.41% -100% $7.00
SNDA
Sonida Senior Living, Inc.
-- -- -- -- $31.50
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
NHC
National HealthCare Corp.
$172.83 -- $2.7B 22.53x $0.64 1.46% 1.79x
AGL
Agilon Health, Inc.
$0.70 $0.94 $289.8M -- $0.00 0% 0.05x
CVS
CVS Health Corp.
$80.57 $96.38 $102.5B 58.24x $0.67 3.3% 0.25x
HUM
Humana, Inc.
$183.11 $223.88 $22.1B 18.67x $0.89 1.93% 0.17x
INNV
InnovAge Holding Corp.
$10.60 $7.00 $1.4B 227.96x $0.00 0% 1.57x
SNDA
Sonida Senior Living, Inc.
$37.34 $31.50 $704.4M -- $0.00 0% 1.82x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
NHC
National HealthCare Corp.
7.53% 0.276 4.55% 1.22x
AGL
Agilon Health, Inc.
22.51% -4.896 12.89% 0.26x
CVS
CVS Health Corp.
51.53% -0.127 79.13% 0.48x
HUM
Humana, Inc.
42.29% -0.185 41.78% 0.00x
INNV
InnovAge Holding Corp.
27.08% 0.790 12.95% 1.02x
SNDA
Sonida Senior Living, Inc.
89.42% 0.179 118.09% 0.35x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
NHC
National HealthCare Corp.
$272.2M $27M 10.3% 11.91% 7.01% $6.4M
AGL
Agilon Health, Inc.
-$97.6M -$156.4M -100.62% -111.79% -9.97% -$30.3M
CVS
CVS Health Corp.
$13.6B $2.3B 1.1% 2.28% 2.19% $2.6B
HUM
Humana, Inc.
-- -$808M 3.94% 6.77% -3.11% -$1.9B
INNV
InnovAge Holding Corp.
$47.9M $16.1M 0.89% 1.21% 6.72% $19M
SNDA
Sonida Senior Living, Inc.
$6M -$10.9M -6.31% -41.74% -11.17% $3M

National HealthCare Corp. vs. Competitors

  • Which has Higher Returns NHC or AGL?

    Agilon Health, Inc. has a net margin of 6.55% compared to National HealthCare Corp.'s net margin of -12.04%. National HealthCare Corp.'s return on equity of 11.91% beat Agilon Health, Inc.'s return on equity of -111.79%.

    Company Gross Margin Earnings Per Share Invested Capital
    NHC
    National HealthCare Corp.
    70.75% $1.58 $1.2B
    AGL
    Agilon Health, Inc.
    -6.22% -$0.46 $163.5M
  • What do Analysts Say About NHC or AGL?

    National HealthCare Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Agilon Health, Inc. has an analysts' consensus of $0.94 which suggests that it could grow by 35.17%. Given that Agilon Health, Inc. has higher upside potential than National HealthCare Corp., analysts believe Agilon Health, Inc. is more attractive than National HealthCare Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    NHC
    National HealthCare Corp.
    0 0 0
    AGL
    Agilon Health, Inc.
    2 13 0
  • Is NHC or AGL More Risky?

    National HealthCare Corp. has a beta of 0.605, which suggesting that the stock is 39.46% less volatile than S&P 500. In comparison Agilon Health, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock NHC or AGL?

    National HealthCare Corp. has a quarterly dividend of $0.64 per share corresponding to a yield of 1.46%. Agilon Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. National HealthCare Corp. pays 32.98% of its earnings as a dividend. Agilon Health, Inc. pays out -- of its earnings as a dividend. National HealthCare Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios NHC or AGL?

    National HealthCare Corp. quarterly revenues are $384.8M, which are smaller than Agilon Health, Inc. quarterly revenues of $1.6B. National HealthCare Corp.'s net income of $25.2M is higher than Agilon Health, Inc.'s net income of -$188.9M. Notably, National HealthCare Corp.'s price-to-earnings ratio is 22.53x while Agilon Health, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National HealthCare Corp. is 1.79x versus 0.05x for Agilon Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NHC
    National HealthCare Corp.
    1.79x 22.53x $384.8M $25.2M
    AGL
    Agilon Health, Inc.
    0.05x -- $1.6B -$188.9M
  • Which has Higher Returns NHC or CVS?

    CVS Health Corp. has a net margin of 6.55% compared to National HealthCare Corp.'s net margin of 2.77%. National HealthCare Corp.'s return on equity of 11.91% beat CVS Health Corp.'s return on equity of 2.28%.

    Company Gross Margin Earnings Per Share Invested Capital
    NHC
    National HealthCare Corp.
    70.75% $1.58 $1.2B
    CVS
    CVS Health Corp.
    12.82% $2.30 $155.3B
  • What do Analysts Say About NHC or CVS?

    National HealthCare Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand CVS Health Corp. has an analysts' consensus of $96.38 which suggests that it could grow by 19.63%. Given that CVS Health Corp. has higher upside potential than National HealthCare Corp., analysts believe CVS Health Corp. is more attractive than National HealthCare Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    NHC
    National HealthCare Corp.
    0 0 0
    CVS
    CVS Health Corp.
    17 5 0
  • Is NHC or CVS More Risky?

    National HealthCare Corp. has a beta of 0.605, which suggesting that the stock is 39.46% less volatile than S&P 500. In comparison CVS Health Corp. has a beta of 0.492, suggesting its less volatile than the S&P 500 by 50.806%.

  • Which is a Better Dividend Stock NHC or CVS?

    National HealthCare Corp. has a quarterly dividend of $0.64 per share corresponding to a yield of 1.46%. CVS Health Corp. offers a yield of 3.3% to investors and pays a quarterly dividend of $0.67 per share. National HealthCare Corp. pays 32.98% of its earnings as a dividend. CVS Health Corp. pays out 191.23% of its earnings as a dividend. National HealthCare Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but CVS Health Corp.'s is not.

  • Which has Better Financial Ratios NHC or CVS?

    National HealthCare Corp. quarterly revenues are $384.8M, which are smaller than CVS Health Corp. quarterly revenues of $105.7B. National HealthCare Corp.'s net income of $25.2M is lower than CVS Health Corp.'s net income of $2.9B. Notably, National HealthCare Corp.'s price-to-earnings ratio is 22.53x while CVS Health Corp.'s PE ratio is 58.24x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National HealthCare Corp. is 1.79x versus 0.25x for CVS Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NHC
    National HealthCare Corp.
    1.79x 22.53x $384.8M $25.2M
    CVS
    CVS Health Corp.
    0.25x 58.24x $105.7B $2.9B
  • Which has Higher Returns NHC or HUM?

    Humana, Inc. has a net margin of 6.55% compared to National HealthCare Corp.'s net margin of -2.39%. National HealthCare Corp.'s return on equity of 11.91% beat Humana, Inc.'s return on equity of 6.77%.

    Company Gross Margin Earnings Per Share Invested Capital
    NHC
    National HealthCare Corp.
    70.75% $1.58 $1.2B
    HUM
    Humana, Inc.
    -- -$6.61 $30.7B
  • What do Analysts Say About NHC or HUM?

    National HealthCare Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Humana, Inc. has an analysts' consensus of $223.88 which suggests that it could grow by 22.26%. Given that Humana, Inc. has higher upside potential than National HealthCare Corp., analysts believe Humana, Inc. is more attractive than National HealthCare Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    NHC
    National HealthCare Corp.
    0 0 0
    HUM
    Humana, Inc.
    6 17 2
  • Is NHC or HUM More Risky?

    National HealthCare Corp. has a beta of 0.605, which suggesting that the stock is 39.46% less volatile than S&P 500. In comparison Humana, Inc. has a beta of 0.440, suggesting its less volatile than the S&P 500 by 55.989%.

  • Which is a Better Dividend Stock NHC or HUM?

    National HealthCare Corp. has a quarterly dividend of $0.64 per share corresponding to a yield of 1.46%. Humana, Inc. offers a yield of 1.93% to investors and pays a quarterly dividend of $0.89 per share. National HealthCare Corp. pays 32.98% of its earnings as a dividend. Humana, Inc. pays out 36% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios NHC or HUM?

    National HealthCare Corp. quarterly revenues are $384.8M, which are smaller than Humana, Inc. quarterly revenues of $32.5B. National HealthCare Corp.'s net income of $25.2M is higher than Humana, Inc.'s net income of -$776M. Notably, National HealthCare Corp.'s price-to-earnings ratio is 22.53x while Humana, Inc.'s PE ratio is 18.67x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National HealthCare Corp. is 1.79x versus 0.17x for Humana, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NHC
    National HealthCare Corp.
    1.79x 22.53x $384.8M $25.2M
    HUM
    Humana, Inc.
    0.17x 18.67x $32.5B -$776M
  • Which has Higher Returns NHC or INNV?

    InnovAge Holding Corp. has a net margin of 6.55% compared to National HealthCare Corp.'s net margin of 4.93%. National HealthCare Corp.'s return on equity of 11.91% beat InnovAge Holding Corp.'s return on equity of 1.21%.

    Company Gross Margin Earnings Per Share Invested Capital
    NHC
    National HealthCare Corp.
    70.75% $1.58 $1.2B
    INNV
    InnovAge Holding Corp.
    20% $0.08 $384.1M
  • What do Analysts Say About NHC or INNV?

    National HealthCare Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand InnovAge Holding Corp. has an analysts' consensus of $7.00 which suggests that it could fall by -33.96%. Given that InnovAge Holding Corp. has higher upside potential than National HealthCare Corp., analysts believe InnovAge Holding Corp. is more attractive than National HealthCare Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    NHC
    National HealthCare Corp.
    0 0 0
    INNV
    InnovAge Holding Corp.
    0 2 0
  • Is NHC or INNV More Risky?

    National HealthCare Corp. has a beta of 0.605, which suggesting that the stock is 39.46% less volatile than S&P 500. In comparison InnovAge Holding Corp. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock NHC or INNV?

    National HealthCare Corp. has a quarterly dividend of $0.64 per share corresponding to a yield of 1.46%. InnovAge Holding Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. National HealthCare Corp. pays 32.98% of its earnings as a dividend. InnovAge Holding Corp. pays out -- of its earnings as a dividend. National HealthCare Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios NHC or INNV?

    National HealthCare Corp. quarterly revenues are $384.8M, which are larger than InnovAge Holding Corp. quarterly revenues of $239.7M. National HealthCare Corp.'s net income of $25.2M is higher than InnovAge Holding Corp.'s net income of $11.8M. Notably, National HealthCare Corp.'s price-to-earnings ratio is 22.53x while InnovAge Holding Corp.'s PE ratio is 227.96x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National HealthCare Corp. is 1.79x versus 1.57x for InnovAge Holding Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NHC
    National HealthCare Corp.
    1.79x 22.53x $384.8M $25.2M
    INNV
    InnovAge Holding Corp.
    1.57x 227.96x $239.7M $11.8M
  • Which has Higher Returns NHC or SNDA?

    Sonida Senior Living, Inc. has a net margin of 6.55% compared to National HealthCare Corp.'s net margin of -27.9%. National HealthCare Corp.'s return on equity of 11.91% beat Sonida Senior Living, Inc.'s return on equity of -41.74%.

    Company Gross Margin Earnings Per Share Invested Capital
    NHC
    National HealthCare Corp.
    70.75% $1.58 $1.2B
    SNDA
    Sonida Senior Living, Inc.
    6.09% -$1.56 $770.8M
  • What do Analysts Say About NHC or SNDA?

    National HealthCare Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Sonida Senior Living, Inc. has an analysts' consensus of $31.50 which suggests that it could fall by -15.64%. Given that Sonida Senior Living, Inc. has higher upside potential than National HealthCare Corp., analysts believe Sonida Senior Living, Inc. is more attractive than National HealthCare Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    NHC
    National HealthCare Corp.
    0 0 0
    SNDA
    Sonida Senior Living, Inc.
    0 2 0
  • Is NHC or SNDA More Risky?

    National HealthCare Corp. has a beta of 0.605, which suggesting that the stock is 39.46% less volatile than S&P 500. In comparison Sonida Senior Living, Inc. has a beta of 0.759, suggesting its less volatile than the S&P 500 by 24.058%.

  • Which is a Better Dividend Stock NHC or SNDA?

    National HealthCare Corp. has a quarterly dividend of $0.64 per share corresponding to a yield of 1.46%. Sonida Senior Living, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. National HealthCare Corp. pays 32.98% of its earnings as a dividend. Sonida Senior Living, Inc. pays out 85.92% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios NHC or SNDA?

    National HealthCare Corp. quarterly revenues are $384.8M, which are larger than Sonida Senior Living, Inc. quarterly revenues of $98M. National HealthCare Corp.'s net income of $25.2M is higher than Sonida Senior Living, Inc.'s net income of -$27.3M. Notably, National HealthCare Corp.'s price-to-earnings ratio is 22.53x while Sonida Senior Living, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National HealthCare Corp. is 1.79x versus 1.82x for Sonida Senior Living, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NHC
    National HealthCare Corp.
    1.79x 22.53x $384.8M $25.2M
    SNDA
    Sonida Senior Living, Inc.
    1.82x -- $98M -$27.3M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Sell
49
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 37x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
42
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Buy
93
NBTX alert for Mar 5

Nanobiotix SA [NBTX] is down 6.71% over the past day.

Sell
45
MRNA alert for Mar 5

Moderna, Inc. [MRNA] is down 8.43% over the past day.

Buy
77
SSRM alert for Mar 5

SSR Mining, Inc. [SSRM] is down 7.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock